BCL2 and neoplasm: Thus, decreased expression of TIMP-3 protein within cancer cells seems to be associated with an aggressive tumor phenotype through its correlations with nuclear and histological grade, expression of the proliferation marker topoIIα and expression of the apoptosis-related indicators, mutant p53 and Bcl-2.